A high-tech screening tool for cervical cancer is facing pushback from more than a dozen patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear.
Consumer Reports highlights a journal article that indicates how many people die every year from medical mistakes in hospitals.
The calorie counting that defined dieting for so long is giving way to other considerations, like the promise of more fiber or natural ingredients
Consumer Reports found a lot of popular table syrup contains a chemical that could cause cancer.
In a north London hospital, scientists are growing noses, ears and blood vessels in a bold attempt to make body parts in the laboratory.
Consumer Reports shows you why food that you might think is healthy really isn't.
An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday.
The report says thousands of children are taken to the emergency room every year after being hit by a TV falling off a dresser or other piece of furniture.
A person who was confirmed with measles traveled to several western Washington public locations while contagious.
Consumer Reports explains why the heartburn medication Nexium is overused and goes over possible alternatives.
A new class of experimental medicines can dramatically lower cholesterol, raising hopes of a fresh option for people who can't tolerate or don't get enough help from Lipitor and other statin drugs that have been used for this for decades.
There's fresh evidence that a lot of young people could be headed for heart trouble. A large study of preteens in Texas found that about one-third of them had borderline or high cholesterol when tested during routine physical exams.
A small study that examined brains from children who died found abnormal patterns of cell growth in autistic children. The research bolsters evidence that something before birth might cause autism, at least in some cases.
The Food and Drug Administration is weighing the benefits and risks of two experimental colon cancer screening tests which use DNA from a patient's stool to detect dangerous tumors and growths.
Almost half of Americans ages 40 to 75 and nearly all men over 60 qualify to consider cholesterol-lowering statin drugs under new heart disease prevention guidelines, an analysis concludes.